# A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

> **NCT00046761** · PHASE2,PHASE3 · TERMINATED · sponsor: **Ono Pharma USA Inc** · enrollment: 1320 (—)

## Conditions studied

- Cerebrovascular Accident

## Interventions

- **DRUG:** ONO-2506

## Key facts

- **NCT ID:** NCT00046761
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-11
- **Primary completion:** 2005-05
- **Final completion:** —
- **Target enrollment:** 1320 (—)
- **Last updated:** 2012-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046761, "A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00046761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*